USD10
ARCT Shares
About Arcturus TherapeuticsArcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.
USD10
ARCT Shares
About Arcturus TherapeuticsArcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.
Stats
TRADING WINDOW
Closed
OPENS AT
Not enough data
MARKET CAP
$171.39M
OPEN PRICE
$6.09
LOW (1Y)
$5.85
HIGH (1Y)
$24.17
LOW (24H)
$6.00
HIGH (24H)
$6.18
VOLUME (24H)
$429.64K
39.33%
Price history
Time | Price | Change |
|---|---|---|
Today | $6.09 | |
1 Day | $6.08 | |
1 Week | $7.10 | |
1 Month | $7.48 | |
1 Year | $13.79 |
Past performance is not a reliable indicator of future results.
Discover more
Popular price predictions
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.